Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus

about

Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus

Item

http://www.wikidata.org/entity/Q36650834

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Hepatic decompensation/serious ...... or recurrent hepatitis C virus

@ast

Hepatic decompensation/serious ...... or recurrent hepatitis C virus

@en

type

Item

label

Hepatic decompensation/serious ...... or recurrent hepatitis C virus

@ast

Hepatic decompensation/serious ...... or recurrent hepatitis C virus

@en

prefLabel

Hepatic decompensation/serious ...... or recurrent hepatitis C virus

@ast

Hepatic decompensation/serious ...... or recurrent hepatitis C virus

@en

P1476

Hepatic decompensation/serious ...... or recurrent hepatitis C virus

@en

P2093

Alyson Harty

http://www.w3.org/2001/XMLSchema#string

Andrea Branch

http://www.w3.org/2001/XMLSchema#string

Charissa Chang

http://www.w3.org/2001/XMLSchema#string

David Motamed

http://www.w3.org/2001/XMLSchema#string

Donald Gardenier

http://www.w3.org/2001/XMLSchema#string

Douglas Dieterich

http://www.w3.org/2001/XMLSchema#string

Gene Im

http://www.w3.org/2001/XMLSchema#string

Jawad Ahmad

http://www.w3.org/2001/XMLSchema#string

Jennifer Leong

http://www.w3.org/2001/XMLSchema#string

Joseph Odin

http://www.w3.org/2001/XMLSchema#string

P2860

Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence

Management of hepatitis C infection before and after liver transplantation

Sofosbuvir for previously untreated chronic hepatitis C infection

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

Management of viral hepatitis in liver transplant recipients

Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting.

Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study.

Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin.

P304

2844-2854

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V22.I9.2844

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

296619730

http://www.w3.org/2001/XMLSchema#string

P698

26973423

http://www.w3.org/2001/XMLSchema#string

P921

sofosbuvir

P932

4778007

http://www.w3.org/2001/XMLSchema#string